Zhi Tong Cai Jing·2025-11-26 04:03Group 1 - The Hang Seng Index rose by 0.46%, gaining 119 points to close at 26,013 points, while the Hang Seng Tech Index increased by 0.51%. The morning trading volume in Hong Kong reached HKD 114 billion [1] - Meituan-W (03690) saw a morning increase of 5.85%, while Alibaba indicated a significant reduction in investment for Taobao Flash Sale expected in the next quarter [1] - Airline stocks performed well, with China Eastern Airlines (00670) rising over 6% due to improved oil cost benefits for airline performance [1] Group 2 - The Hang Seng Biotechnology Index increased by over 2%, with Rongchang Biologics (09995) rising over 5% and Kangfang Biologics (09926) up over 4% [2] - China Biopharmaceutical (01177) rose by 2.59% after its subsidiary achieved a significant breakthrough in HER2 dual-target ADC for breast cancer [2] - Junshi Biosciences (01877) increased by over 3% as its Toripalimab subcutaneous injection Phase III clinical trial met its primary endpoint, with plans for subsequent listing application [2] - Basilea Pharmaceutica-B (02616) rose over 6% after the European Commission approved a new indication for Sugliumab [2] - GDS Holdings Limited-SW (09698) increased by nearly 4% as domestic AI chip supply improves, with Morgan Stanley expecting a surge in orders in the second half of next year [2] Group 3 - Changfei Optical Fiber (601869) and Optical Cable (06869) rose nearly 7%, driven by interest in Google's TPU chips, with institutions optimistic about AI-driven growth in data communication [3] - Smoore International (06969) increased by over 4% after signing a long-term procurement agreement for battery cells with EVE Energy (300014) to secure supply for electronic cigarette products [3] - Alibaba-W (09988) fell over 2% as its adjusted net profit for the second fiscal quarter decreased by 72% year-on-year [3]